These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29844554)

  • 1. Improved metrics for Huntington's disease trials.
    Arney K
    Nature; 2018 May; 557(7707):S46-S47. PubMed ID: 29844554
    [No Abstract]   [Full Text] [Related]  

  • 2. How the gene behind Huntington's disease could be neutralized.
    Drew L
    Nature; 2018 May; 557(7707):S39-S41. PubMed ID: 29844556
    [No Abstract]   [Full Text] [Related]  

  • 3. Huntington's disease: 4 big questions.
    Nowogrodzki A
    Nature; 2018 May; 557(7707):S48. PubMed ID: 29844555
    [No Abstract]   [Full Text] [Related]  

  • 4. Is Huntington's disease on the threshold of a new era in treatment?
    Sandy S; Richard A
    Neurodegener Dis Manag; 2019 Oct; 9(5):255-258. PubMed ID: 31580228
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of genetic therapies for Huntington's devastates community.
    Kwon D
    Nature; 2021 May; 593(7858):180. PubMed ID: 33963316
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-sense oligonucleotides RNA therapy in Huntington disease: a great promise and many unknowns].
    Durr A
    Med Sci (Paris); 2019 Nov; 35(11):834-836. PubMed ID: 31845872
    [No Abstract]   [Full Text] [Related]  

  • 7. Antisense oligonucleotides for neurodegeneration.
    Leavitt BR; Tabrizi SJ
    Science; 2020 Mar; 367(6485):1428-1429. PubMed ID: 32217715
    [No Abstract]   [Full Text] [Related]  

  • 8. Huntington's disease: a decade beyond gene discovery.
    Hogarth P
    Curr Neurol Neurosci Rep; 2003 Jul; 3(4):279-84. PubMed ID: 12930696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double setback for ASO trials in Huntington disease.
    Kingwell K
    Nat Rev Drug Discov; 2021 Jun; 20(6):412-413. PubMed ID: 34012000
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictive testing and clinical trials in Huntington's disease: An ethical analysis.
    Sampaio C; Levey J; Klitzman R
    Mov Disord; 2018 Feb; 33(2):243-247. PubMed ID: 29205501
    [No Abstract]   [Full Text] [Related]  

  • 11. The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
    Leegwater-Kim J; Cha JH
    NeuroRx; 2004 Jan; 1(1):128-38. PubMed ID: 15717013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease.
    Cubo E; González M; del Puerto I; de Yébenes JG; Arconada OF; Gabriel y Galán JM;
    Mov Disord; 2012 Mar; 27(3):439-42. PubMed ID: 22162184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington's Disease.
    Bardakjian TM; Naczi KF; Gonzalez-Alegre P
    J Huntingtons Dis; 2019; 8(1):79-85. PubMed ID: 30689592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on Huntington's disease: from the gene to the clinic.
    Kim SD; Fung VS
    Curr Opin Neurol; 2014 Aug; 27(4):477-83. PubMed ID: 24978638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting a handle on Huntington's disease: silencing neurodegeneration.
    La Spada AR
    Nat Med; 2009 Mar; 15(3):252-3. PubMed ID: 19265826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular therapeutic strategies for Huntington's disease].
    Milewski M; Hoffman-Zacharska D; Ball J
    Postepy Biochem; 2015; 61(1):18-24. PubMed ID: 26281350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Trials Corner: September 2017.
    Rodrigues FB; Wild EJ
    J Huntingtons Dis; 2017; 6(3):255-263. PubMed ID: 28968245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical considerations in gene therapy of Huntington's disease.
    MacMillan JC; Snell RG; Harper PS
    Gene Ther; 1994; 1 Suppl 1():S88. PubMed ID: 8542434
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in Huntington's disease: implications for experimental therapeutics.
    Feigin A; Zgaljardic D
    Curr Opin Neurol; 2002 Aug; 15(4):483-9. PubMed ID: 12151847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's disease: an update of therapeutic strategies.
    Kumar A; Kumar Singh S; Kumar V; Kumar D; Agarwal S; Rana MK
    Gene; 2015 Feb; 556(2):91-7. PubMed ID: 25447911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.